In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
I. Jolanda M. de Vries(Radboud University Nijmegen), Gosse J. Adema(Radboud University Nijmegen), Winny L. van Geloof(Radboud University Nijmegen), D. J. Ruiter(Radboud University Nijmegen), Cornelis J.A. Punt(Utrecht University), Carl G. Figdor(Radboud University Nijmegen), Monique R. Bernsen(Radboud University Nijmegen), Nicole M. Scharenborg(Radboud University Nijmegen), Paul Rombout(Radboud University Nijmegen), Goos N.P. van Muijen(Radboud University Medical Center), W. Joost Lesterhuis(Radboud University Nijmegen)
Cited by 26
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
|Nature Biotechnology|2005|823